Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $203.67 million. The enterprise value is $174.36 million.
| Market Cap | 203.67M |
| Enterprise Value | 174.36M |
Important Dates
The next estimated earnings date is Friday, May 9, 2025, before market open.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 78.03 million shares outstanding. The number of shares has decreased by -1.66% in one year.
| Current Share Class | 78.03M |
| Shares Outstanding | 78.03M |
| Shares Change (YoY) | -1.66% |
| Shares Change (QoQ) | +28.45% |
| Owned by Insiders (%) | 10.71% |
| Owned by Institutions (%) | 6.58% |
| Float | 59.15M |
Valuation Ratios
The trailing PE ratio is 71.21 and the forward PE ratio is 6.07.
| PE Ratio | 71.21 |
| Forward PE | 6.07 |
| PS Ratio | 3.55 |
| Forward PS | 2.94 |
| PB Ratio | 4.58 |
| P/TBV Ratio | 4.71 |
| P/FCF Ratio | 27.55 |
| P/OCF Ratio | 23.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.40, with an EV/FCF ratio of 23.59.
| EV / Earnings | 59.47 |
| EV / Sales | 3.27 |
| EV / EBITDA | 33.40 |
| EV / EBIT | 44.51 |
| EV / FCF | 23.59 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.34 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | 0.75 |
| Interest Coverage | 3.69 |
Financial Efficiency
Return on equity (ROE) is 7.64% and return on invested capital (ROIC) is 4.51%.
| Return on Equity (ROE) | 7.64% |
| Return on Assets (ROA) | 3.10% |
| Return on Invested Capital (ROIC) | 4.51% |
| Return on Capital Employed (ROCE) | 8.20% |
| Revenue Per Employee | $250,700 |
| Profits Per Employee | $13,765 |
| Employee Count | 213 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, PLX has paid $1.22 million in taxes.
| Income Tax | 1.22M |
| Effective Tax Rate | 29.42% |
Stock Price Statistics
The stock price has increased by +128.95% in the last 52 weeks. The beta is 0.46, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +128.95% |
| 50-Day Moving Average | 2.45 |
| 200-Day Moving Average | 1.66 |
| Relative Strength Index (RSI) | 58.76 |
| Average Volume (20 Days) | 619,777 |
Short Selling Information
The latest short interest is 979,388, so 1.26% of the outstanding shares have been sold short.
| Short Interest | 979,388 |
| Short Previous Month | 5.05M |
| Short % of Shares Out | 1.26% |
| Short % of Float | 1.66% |
| Short Ratio (days to cover) | 1.26 |
Income Statement
In the last 12 months, PLX had revenue of $53.40 million and earned $2.93 million in profits. Earnings per share was $0.04.
| Revenue | 53.40M |
| Gross Profit | 29.08M |
| Operating Income | 3.92M |
| Pretax Income | 6.77M |
| Net Income | 2.93M |
| EBITDA | 5.22M |
| EBIT | 3.92M |
| Earnings Per Share (EPS) | $0.04 |
Balance Sheet
The company has $34.83 million in cash and $5.53 million in debt, giving a net cash position of $29.30 million or $0.38 per share.
| Cash & Cash Equivalents | 34.83M |
| Total Debt | 5.53M |
| Net Cash | 29.30M |
| Net Cash Per Share | $0.38 |
| Equity (Book Value) | 43.21M |
| Book Value Per Share | 0.57 |
| Working Capital | 34.46M |
Cash Flow
In the last 12 months, operating cash flow was $8.67 million and capital expenditures -$1.28 million, giving a free cash flow of $7.39 million.
| Operating Cash Flow | 8.67M |
| Capital Expenditures | -1.28M |
| Free Cash Flow | 7.39M |
| FCF Per Share | $0.09 |
Margins
Gross margin is 54.46%, with operating and profit margins of 7.34% and 5.49%.
| Gross Margin | 54.46% |
| Operating Margin | 7.34% |
| Pretax Margin | 7.78% |
| Profit Margin | 5.49% |
| EBITDA Margin | 9.78% |
| EBIT Margin | 7.34% |
| FCF Margin | 13.84% |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.66% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.44% |
| FCF Yield | 3.63% |
Analyst Forecast
The average price target for PLX is $15.00, which is 474.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 474.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
PLX has an Altman Z-Score of -3.88 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.88 |
| Piotroski F-Score | 5 |